Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > ALPL


Brief Information

Name:Alkaline phosphatase, tissue-nonspecific isozyme
Target Synonym:Alkaline Phosphatase, Biomineralization Associated,EC:,Alkaline Phosphatase Liver/Bone/Kidney Isozyme,Liver/Bone/Kidney-Type Alkaline Phosphatase,ALPL,AP-TNAP,Alkaline Phosphatase, Liver/Bone/Kidney,Tissue Non-Specific Alkaline Phosphatase,TNSALP,Alkaline Phosphatase, Tissue-Nonspecific Isozyme,Tissue-Nonspecific ALP,EC,APTNAP,TNALP,TNAP,HOPS
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
Cat. No. Species Product Description Structure Purity Feature
ALL-HR2H3 Human HRP-Human ALPL Protein, His Tag
ALL-H52H3 Human Human ALPL Protein, His Tag (active enzyme, MALS verified)
ACRO Quality

Part of Bioactivity data

ALPL MALS images

The purity of Human ALPL Protein, His Tag (Cat. No. ALL-H52H3) is more than 90% and the molecular weight of this protein is around 115-135 kDa verified by SEC-MALS.


Immobilized Human ALPL Protein, His Tag (Cat. No. ALL-H52H3) at 1 μg/mL (100 μL/well) can bind various dilution ratio of Anti-ALPL Polyclonal Antibody (QC tested).

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Asfotase alfa sTNALP-FcD10; ALXN-1215; sALP-FcD10; ENB-0040 Approved Alexion Pharmaceuticals Inc Strensiq Japan Hypophosphatasia Alexion Pharmaceuticals Inc 2015-07-03 Hypophosphatasia Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
ALXN-1850 ALXN-1850 Phase 3 Clinical Alexion Pharmaceuticals Inc Hypophosphatasia Details
DS-1211 DS-1211 Phase 2 Clinical Sanford Burnham Prebys Medical Discovery Institute, Daiichi Sankyo Co Ltd Ossification, Heterotopic; Pseudoxanthoma Elasticum Details
ALXN-1910 ALXN-1910 Phase 1 Clinical Alexion Pharmaceuticals Inc Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message